CEVR analyzes the value of strategies to improve health and health care.

About Us

News & Events

Call for Papers: 2024 Tufts-CEVR Cost-Effectiveness Analysis Paper of the Year

Call for Papers! 2024 Tufts-CEVR Cost-Effectiveness Analysis Paper of the Year The Center for the Evaluation of Value and Risk in Health (CEVR) at T...

Read more November 11, 2024
CEVR Announces Two New Members of CEA Registry Scientific Advisory Board

CEVR Announces Two New Members of CEA Registry Scientific Advisory Board CEVR is pleased to welcome two new advisors to the Cost-Effectiveness Analysi...

Read more November 11, 2024
CEVR Participation at ISPOR Europe 2024

CEVR faculty will present their research during several discussion and poster sessions at ISPOR Europe 2024 in Barcelona: Monday, November 19 Breakou...

Read more November 6, 2024
View All News & Events

Recent Publications

STAT
Medicare’s new transitional coverage of emerging technologies program doesn’t go far enough
View publication
August 28, 2024
Value in Health
The health benefits, costs, and cost-effectiveness of ultraorphan drugs
View publication
July 31, 2024
Health Affairs Forefront
Improving how CMS defines “unmet medical need” under the IRA
View publication
July 30, 2024
Clinical Therapeutics
Balancing evidence and need: variation in US commercial payer coverage of Esketamine
View publication
July 21, 2024
Health Affairs Scholar
Biosimilar underutilization alone does not foretell a broken biologics market
View publication
July 17, 2024
Value in Health
A roadmap for improving Medicare's application of coverage with evidence development
View publication
May 23, 2024
Journal of the American Geriatrics Society
Racial and ethnic differences in disease course Medicare expenditures for beneficiaries with dementia
View publication
March 20, 2024
Value in Health
It's time to reconsider the three percent discount rate
View publication
March 8, 2024
Health Affairs Forefront
Are We Valuing Prescription Drugs Appropriately?
View publication
February 5, 2024
Journal of Alzheimer's Disease
Life-Sustaining Treatments Among Medicare Beneficiaries with and without Dementia at the End of Life
View publication
November 21, 2023
Health Policy Open
Variation in Medicaid and commercial coverage of cell and gene therapies
View publication
December 15, 2023
Health Affairs Forefront
The Case For Including Dynamic Drug Pricing In Cost-Effectiveness Analyses Under The IRA
View publication
October 18, 2023
Cost Effectiveness and Resource Allocation
Assessing the impact of grief on quality of life, work productivity, and health outcomes for parents bereaved from SMA: A study protocol
View publication
August 23, 2023
View All Publications

The CEVR Team

Our team of experienced, dedicated researchers is led by health economists Peter Neumann and Josh Cohen. Together we produce cutting-edge health care cost-effectiveness research.

Meet the CEVR Team

Our Databases

Our comprehensive databases provide the information individuals and organizations need to analyze the benefits, risks, and costs of strategies to improve health and health care.

CEA Registry

The CEA Registry is a comprehensive database of 9,080 cost-utility analyses on a wide variety of diseases and treatments.

View Registry

Global Health CEA Registry

The GH CEA Registry is the first comprehensive database to compile articles utilizing the “cost-per-DALY averted” metric to measure the efficacy of health interventions.

View Registry

SPEC Database

The Specialty Drug Evidence and Coverage (SPEC) Database is a new data resource developed with the goal of providing an empirical basis to commercial payer specialty drug coverage.

View Database
Learn About Our Databases